Home > Insider Trading > Filing (0001209191-20-059059)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Adm, Leg & Bd Off	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-11-16	26	$222.52	26,903	No	4	S	Direct
Common Stock	Disposition	2020-11-16	40	$223.67	26,863	No	4	S	Direct
Common Stock	Disposition	2020-11-16	25	$224.34	26,838	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $222.52 (range $221.98 to $222.97).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $223.67 (range $223.01 to $224.00).
Open market sales reported on this line occurred at a weighted average price of $224.34 (range $224.02 to $224.92).